Ofloxacino Pos Brill Pharma (Ofloxacin)

Ofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria in several organ systems.

• Eye infections: helps eradicate bacterial conjunctivitis and keratitis.
• Respiratory tract infections: aids in the treatment of acute exacerbations of chronic bronchitis and community‑acquired pneumonia.
• Urinary tract infections: eliminates pathogens responsible for uncomplicated cystitis and pyelonephritis.
• Skin and soft‑tissue infections: assists in clearing bacterial cellulitis and wound infections.
• Sexually transmitted infections: used for uncomplicated gonorrhoea caused by susceptible strains.

• Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription and repair. By binding to these enzymes, the drug prevents the supercoiling and relaxation of bacterial DNA, leading to inhibition of bacterial cell division and ultimately bacterial cell death. This bactericidal action is effective against a wide range of Gram‑negative and Gram‑positive organisms.

Ofloxacin may cause a range of adverse reactions, from mild to severe, depending on individual susceptibility and treatment duration.

Common Side Effects

• Nausea: mild stomach upset often reported.
• Diarrhea: loose stools occurring during therapy.
• Headache: transient head pain without neurological signs.
• Dizziness: occasional light‑headed sensation.
• Skin rash: mild erythema or itching.
• Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or rupture, especially in the Achilles.
• QT prolongation: cardiac rhythm changes that may lead to arrhythmia.
• Severe allergic reaction: anaphylaxis, angioedema or bronchospasm.
• Peripheral neuropathy: tingling, numbness or weakness in extremities.
• Hepatotoxicity: elevated liver enzymes or jaundice.
• Central nervous system effects: seizures or psychosis.

When using Ofloxacin, clinicians should assess patient history and monitor for specific safety concerns.

• Renal impairment: adjust dose in patients with reduced kidney function.
• Hepatic disease: use with caution in liver dysfunction.
• Pregnancy and lactation: avoid unless clearly needed, as risks to the fetus or infant are not fully known.
• Concomitant QT‑prolonging drugs: monitor cardiac rhythm when combined with other agents that affect QT interval.
• Tendon disorders: advise patients to report tendon pain, especially if engaged in vigorous activity.
• Age considerations: use cautiously in the elderly due to higher risk of adverse events.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ofloxacin can interact with several medicines, altering its effectiveness or increasing toxicity risk.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce absorption of Ofloxacin.
• Warfarin: may increase anticoagulant effect and bleeding risk.
• Cyclosporine: heightened risk of neurotoxicity.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation.
• Theophylline: potential for increased serum concentrations.
• Corticosteroids: may raise the chance of tendon rupture.
• Diabetic agents: possible alteration of blood glucose control.